Treatment of Stable Angina in Microvascular Angina
Microvascular angina is a distinct clinical setting for stable angina. Patients in this scenario require antianginal management specifically suited to this diagnosis.
Stable angina in the setting of microvascular angina. Antianginal therapy for this population follows specific guideline-supported recommendations.
Control and relief of angina symptoms through therapy appropriate for the microvascular setting.
Specific antianginal agents are identified as preferred for microvascular angina. The full protocol — including agent selection and clinical criteria — is accessible below.
DOI: 10.1093/eurheartj/ehae177
Consideration for initial therapy: ivabradine, nicorandil, long-acting nitrates, ranolazine, or trimetazidine for patients with intolerance or contraindications to beta-blockers and/or CCBs; ranolazine and trimetazidine for patients with microvascular angina; nicorandil or nitrates for patients with coronary artery spasm.
View source ↗